Pancreatic cancer

Results: 663



#Item
1IJC International Journal of Cancer Acetyl-11-keto-b-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression

IJC International Journal of Cancer Acetyl-11-keto-b-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression

Add to Reading List

Source URL: www.adonito.com

Language: English - Date: 2016-10-13 11:54:44
    2Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

    Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

    Add to Reading List

    Source URL: www.xentech.eu

    Language: English - Date: 2015-12-22 11:05:02
      3Endometrial cancer (LUK) Kidney cancer (LUK) Pancreatic cancer Stomach cancer I)

      Endometrial cancer (LUK) Kidney cancer (LUK) Pancreatic cancer Stomach cancer I)

      Add to Reading List

      Source URL: natamcancer.org

      Language: English - Date: 2014-03-03 17:48:07
        4

        Exercise – Viewing gene features on the mouse karyotype Several variants seem to be associated with pancreatic cancer. Here is a non-exhaustive list of genes where these variants have been mapped to in humans: ABO, TP

        Add to Reading List

        Source URL: ftp.ebi.ac.uk

        Language: English - Date: 2018-03-06 08:50:02
          5David Mundy The role of the SWI/SNF complexes in pancreatic cancer Pancreatic ductal adenocarcinoma, known colloquially as pancreatic cancer (PC), is the eighth leading cause of cancer-related mortality worldwide1. Due t

          David Mundy The role of the SWI/SNF complexes in pancreatic cancer Pancreatic ductal adenocarcinoma, known colloquially as pancreatic cancer (PC), is the eighth leading cause of cancer-related mortality worldwide1. Due t

          Add to Reading List

          Source URL: biochem158.stanford.edu

          Language: English - Date: 2014-06-17 08:43:55
            6INSTRUCTION FOR AUTHORS Thank you for your interest in Annals of Pancreatic Cancer (APC). Please consult the following instructions to help you prepare your manuscript, and feel free to contact us with any questions. To

            INSTRUCTION FOR AUTHORS Thank you for your interest in Annals of Pancreatic Cancer (APC). Please consult the following instructions to help you prepare your manuscript, and feel free to contact us with any questions. To

            Add to Reading List

            Source URL: apc.amegroups.com

            - Date: 2018-01-04 20:56:24
              7Annals of Pancreatic Cancer PUBLICATION ETHICS STATEMENT General duties and responsibilities of editors Editors should be responsible for everything published in their journals. They should: • strive to meet the needs

              Annals of Pancreatic Cancer PUBLICATION ETHICS STATEMENT General duties and responsibilities of editors Editors should be responsible for everything published in their journals. They should: • strive to meet the needs

              Add to Reading List

              Source URL: apc.amegroups.com

              - Date: 2016-12-23 07:36:56
                8Annals of Pancreatic Cancer Instructions for reviewers Annals of Pancreatic Cancer ( Ann Pancreat Cancer) is a journal for all researchers in the field of pancreatic cancer and for all health care providers who manage t

                Annals of Pancreatic Cancer Instructions for reviewers Annals of Pancreatic Cancer ( Ann Pancreat Cancer) is a journal for all researchers in the field of pancreatic cancer and for all health care providers who manage t

                Add to Reading List

                Source URL: apc.amegroups.com

                - Date: 2016-12-23 07:36:46
                  9Final Results of a Phase 1b of Tarextumab (OMP-59R5) (anti-Notch2/3 antibody) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Stu

                  Final Results of a Phase 1b of Tarextumab (OMP-59R5) (anti-Notch2/3 antibody) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Stu

                  Add to Reading List

                  Source URL: s3.amazonaws.com

                  - Date: 2014-09-25 16:16:37
                    10Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Colin Weekes,1

                    Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC) Colin Weekes,1

                    Add to Reading List

                    Source URL: publications.oncomed.com

                    - Date: 2016-10-09 05:13:10